Hetero-oligomers of α2A-adrenergic and μ-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles

Biochemical Society Transactions

Volumn 32, Issue 5, 2004, Pages 856-860

  Zhang, Y Q ^a   Limbird, L E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2A adrenergic receptor; opioid receptor; G protein coupled receptor; Hetero oligomer

Indexed keywords

ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; PERTUSSIS TOXIN; SULFUR 35; ALPHA 2 ADRENERGIC RECEPTOR; COMPLEMENTARY DNA; HYBRID PROTEIN; NARCOTIC ANALGESIC AGENT; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A;

ANIMAL CELL; BINDING AFFINITY; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; INTERNALIZATION; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TRANSACTIVATION; WESTERN BLOTTING; ARTICLE; CELL LINE; CHEMISTRY; FLUORESCENCE MICROSCOPY; METABOLISM; NERVE CELL; PROTEIN BINDING;

ANIMALIA;

ANALGESICS, OPIOID; BLOTTING, WESTERN; CELL LINE; DNA, COMPLEMENTARY; ENDOCYTOSIS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; NEURONS; PERTUSSIS TOXIN; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 8744259035     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0320856     Document Type: Conference Paper

References (18)

1. Jordan, B.A. and Devi, L.A. (1999) Nature (London) 399, 697-700
2. Lavoie, C., Mercier, J.F., Salahpour, A., Umapathy, D., Breit, A., Villeneuve, L.R., Zhu, W.Z., Xiao, R.P., Lakatta, E.G., Bouvier, M. et al. (2002) J. Biol. Chem. 277, 35402-35410
3. Pfeiffer, M., Kirscht, S., Stumm, R., Koch, T., Wu, D., Laugsch, M., Schroder, H., Hollt, V. and Schulz, S. (2003) J. Biol. Chem. 278, 51630-51637
4. Rios, C.D., Jordan, B.A., Gomes, I. and Devi, L.A. (2001) Pharmacol. Ther. 92, 71-87
5. Angers, S., Salahpour, A. and Bouvier, M. (2002) Annu. Rev. Pharmacol. Toxicol. 42, 409-435
6. Milligan, G., Ramsay, D., Pascal, G. and Carrillo, J.J. (2003) Life Sci. 74, 181-188
7. Stone, L.S., MacMillan, L.B., Kitto, K.F., Limbird, L.E. and Wilcox, G.L. (1997) J. Neurosci. 17, 7157-7165
8. Jordan, B.A., Gomes, I., Rios, C., Filipovska, J. and Devi, L.A. (2003) Mol. Pharmacol. 64, 1317-1324
9. McLean, A.J., Zeng, F.Y., Behan, D., Chalmers, D. and Milligan, G. (2002) Mol. Pharmacol. 62, 747-755
10. Wilson, M.H., Highfield, H.A. and Limbird, L.E. (2001) Mol. Pharmacol. 59, 929-938
11. Jordan, B.A., Trapaidze, N., Gomes, I., Nivarthi, R. and Devi, L.A. (2001) Proc. Natl. Acad. Sci. U.S.A. 98, 343-348
12. Hebert, T.E., Moffett, S., Morello, J.P., Loisel, T.P., Bichet, D.G., Barret, C. and Bouvier, M. (1996) J. Biol. Chem. 271, 16384-16392
13. Carrillo, J.J., Pediani, J. and Milligan, G. (2003) J. Biol. Chem. 278, 42578-42587
14. Molinari, P., Ambrosio, C., Riitano, D., Sbraccia, M., Gro, M.C. and Costa, T. (2003) J. Biol. Chem. 278, 15778-15788
15. Schramm, N.L. and Limbird, L.E. (1999) J. Biol. Chem. 274, 24935-24940
16. Keith, D.E., Anton, B., Murray, S.R., Zaki, P.A., Chu, P.C., Lissin, D.V., Monteillet-Agius, G., Stewart, P.L., Evans, C.J. and von Zastrow, M. (1998) Mol. Pharmacol. 53, 377-384
17. Salahpour, A., Bonin, H., Bhalla, S., Petaja-Repo, U. and Bouvier, M. (2003) Biol. Chem. 384, 117-123
18. White, J.H., Wise, A., Main, M.J., Green, A., Fraser, N.J., Disney, G.H., Barnes, A.A., Emson, P., Foord, S.M. and Marshall, F.H. (1998) Nature (London) 396, 679-682